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ABSTRACT 
We use the molecular techniques of PCR and PFGE to identify MRSA from clinical isolates of Staphylococcus aureus 
causing infections among hospitalized patients in Benin-City, Nigeria. A total of 36 isolates were obtained from the 
University of Benin Teaching Hospital between July-September, 2007. The MRSA strains were selected according to their 
phenotypic characteristics (antibiotic resistant profiles), susceptibility to oxacillin by E-test, and detection of β-lactamase. 
This was verified by a latex agglutination test for PBP2a production combined with PCR for mecA gene carriage. Four 
isolates representing 11% were confirmed as MRSA according to the molecular techniques used with two PFGE types (H 
and L) and one agr type (1). Multi resistance to the various antibiotics used was observed in one of the clones. The isolation 
of MRSA in health institution indicates that adequate steps in limiting spread are urgently needed. Also, for the first time 
two MRSA clones according to the PFGE classifications have been identified in Nigeria.  
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INTRODUCTION 
Since 1961, Methicillin-resistant Staphylococcus 
aureus (MRSA) strains have assumed increasing 
importance internationally as a cause of both 
nosocomial and community-acquired infections (1). 
A recent United States study found that Infections 
caused by MRSA result in increased lengths of 
hospital stay, health care costs, morbidity and 
mortality when compared to those caused by 
methicillin-sensitive Staphylococcus aurues (MSSA) 
(2). Although the presence of MRSA in the Asia-
Pacific region has been well recorded, data on the 
true prevalence of MRSA in the region are limited. 
Data from Australia have been published and 
shown that in hospital isolates from the Eastern 
Seaboard, the percentage of S. aureus that were 
MRSA remained relatively constant at 
approximately 30% from 1986 to 1994. 
Soon after the first reports of methicillin resistance 
in S. aureus in 1961, the unusual behaviour of the 
strains in susceptibility tests were noted. Early 
reports indicated that the MRSA were heterogenous 
in their expressions of resistance to β-lactam agents, 
in that large differences in the degree of resistance 
were seen among the individual cells in a 
population (3). Infection control measures, such as 
placing hospitalized patients colonized or infected 
with MRSA in contact precautions (the use of 
gowns and gloves), have been demonstrated to 
limit the spread of this pathogen (4). The use of 
surveillance cultures (e.g anterior nares, axillae and 
perineum) greatly improves the detection of MRSA 
colonization compared to clinical cultures alone.  
 
The anterior nares are the most frequent site of 
MRSA colonization, with a single culture of this site 
having a sensitivity of approximately 85% (5). 
Antimicrobial resistance of S. aureus especially 
MRSA continues to be a problem for clinicians 
worldwide. However, few data on the antibiotic 
susceptibility patterns of S. aureus isolates in South 
Africa have been reported and the prevalence of 
MRSA in the KwaZulu-Natal (KZN) province (6). 
Methicillin resistance in Staphylococcus spp. is 
primarily mediated by the mecA gene, encoding 
penicillin-binding protein 2a (PBP2a). This protein 
has reduced affinity for β-lactam antibiotics. 
Because the mecA gene is heterogeneously 
expressed in vitro selective media are necessary to 
facilitate recovery of MRSA in cultures (7). 
The time from culture inoculation to identification 
of MRSA is typically 48 h, with some methods 
taking as long as 96 h (8) with sensitivity of any 
single selective medium ranging between 65 and 
100%. Several techniques to shorten the time of 
identification of MRSA in the laboratory have been 
developed in the last decade, including slide latex 
agglutination assays to detect PBP2a, a colorimetric 
cycling probe assay to directly detect the mecA gene 
(9), a real-time PCR method to detect the mecA gene 
(10) in conjunction with S. aureus-specific genome 
fragments, such as nuc and sa442.  
Although data on the prevalence of MRSA 
infections in Africa are limited, one of the earliest 
reports in the continent was in South Africa (11). 
Studies in the 1980s and 1990s on MRSA in South 
Africa have also been described (12). The recent 
reports of S. aureus intermediately resistant to 
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vancomycin and teicoplanin in Africa (13) also 
indicate that information on antibiotic resistance is 
critical for optimal decisions regarding hospital 
formulary and infection control policies. In 
addition, characterization of strains is important in 
understanding the epidemiology of S.aureus and 
evaluating the effectiveness of infection control and 
antimicrobial prescribing measures (14).  
The main objective of this study was to use the 
molecular techniques of Polymerase Chain Reaction 
(PCR) and Pulsed Field Gel Electrophoresis (PFGE) 
to identify MRSA from clinical isolates of S.aureus 
causing infections among hospitalized patients in 
Benin-City, Nigeria. 
 
MATERIALS AND METHODS 
Study area – a total of 36 clinical isolates of 
Staphylococcus aureus were obtained from 
hospitalized patients at the University of Benin 
Teaching Hospital, Benin City Nigeria between 
July-September, 2007. Identification and 
confirmation of isolates were conducted based on 
growth and fermentation on mannitol salt agar 
(MSA), colonial morphology, Gram staining and 
positive results to both catalase and coagulase tests. 
Identification of MRSA 
The MRSA strains were selected according to their 
phenotypic characteristics (antibiotic resistant 
profiles), susceptibility to oxacillin by E-test (AB 
Biodisk), and detection of β-lactamase. This was 
verified by a latex agglutination test (bioMerieux) 
for PBP2a production combined with PCR for mecA 
gene carriage.  
 
Extraction of chromosomal DNA 
DNA was extracted by suspending portions of four 
to five colonies in 1ml dH2O equivalent to 2MF, 
centrifuged for 10mins at 13000rpm. The 
supernatant was rejected and the sediment resolved 
with 100ml lysis buffer (50mM Tris-HCl pH=7.5, 1% 
Triton X-100, 1mM EDTA pH=8.0) + 0.2 µl 
proteinase K (1µl/ml from stock 20mg/ml). Initial 
incubation was done at 56oC for 1 hour followed by 
95oC for 10mins. The DNA extracts were stored at -
20oC prior to use. PCR for the presence of the gene 
lin was used to test for the quality of the DNA 
extracts (15). 
Classification of MRSA strains was performed by 
PCRs according to agr groups (16). The presence of 
toxin genes (tst, PVL, egc) was investigated by PCRs 
using specific primers and programmes (17). 
Chromosomal DNA extraction of MRSA was 
performed into agarose disks and clonal types was 
defined by PFGE of SmaI digests (18, 19). 
 
Latex agglutination test for PBP2a production 
The test was performed according to the 
manufacturer's instructions. Briefly, the isolates 
were subcultured onto blood agar at 37°C for 18 
hours to obtain fresh growth. A loopful of cells was 
suspended in four drops of extraction reagent 1 and 
was placed in a boiling water bath for 3 minutes. 
After allowing the suspension to cool to room 
temperature (approx.10 minutes), one drop of 
extraction reagent 2 was added and the mixture 
was vortexed thoroughly. The suspension was then 
centrifuged at 4500 rpm for 5 minutes. The latex 
agglutination test was performed with the 
supernatant, and 50µl of the supernatant was mixed 
with a drop of sensitized latex. For the negative 
control, 50 µl of the supernatant was mixed with 1 
drop of negative control latex. The samples were 
mixed for 3 minutes on a shaker and the results 
were evaluated according to the following plan: 
Sensitized latex   Control latex   Results 
+         -   MRSA 
-        -   MSSA 
-       +   Undetermined 
 
RESULTS 
A total of thirty-six S. aureus isolates collected from 
hospitalized patients in Benin-City, Nigeria 
between July and September 2007 were used in this 
study. Four isolates representing 11% were 
confirmed as MRSA (Table 1) according to the 
molecular techniques used with two PFGE types (H 
and L) (Figure 1) and one agr type (1). Multi 
resistance to the various antibiotics used was 
observed in one of the clones. There was no 
detection of any toxin genes from the strains (Table 
2). 
 
TABLE 1: PREVALENCE OF MRSA AMONG THE CLINICAL ISOLATES OF S.AUREUS 
 
Number of S. aureus isolates MRSA % 














TABLE 2: RESULTS OF GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF THE 4 MRSA STRAINS 
 
PFGE type agr Antibiotic resistance Toxin gene 
(PVL, tst, sem, seg) 
No. of strains 
H 1 K, ER, SXT - 2 
L 1 Multiresistant - 2 
TOTAL    4 





FIGURE 1: PFGE showing large genomic DNA 
fragments after digestion with restriction enzymes 
(Standard controls and test strains). Since the bacterial 
chromosome is typically a circular molecule, this 
digestion yields several linear molecules of DNA. After 
digestion of the DNA and electrophoresis through an 
agarose gel, if the DNA banding pattern between any 
two isolates is identical, then these isolates are 
considered the same strain. Conversely, if two isolates 
are not the same strain, then the sites at which the 
restriction enzymes act on the DNA and the length 
between these sites would be different; thus their DNA 




Antimicrobial resistance has been noticed as one of 
the paramount microbial threats in the twenty-first 
century (20). S. aureus has always been a stumbling 
block for antimicrobial chemotherapy and the 
introduction of new classes of antimicrobial agents 
is usually followed by the emergence of resistant 
forms of this pathogen (21). Surveillance on the 
antimicrobial susceptibility patterns of S. aureus is 
important in understanding new and emerging 
resistance trends and in the management of both 
hospital and community-acquired infections. 
Methicillin resistance of S.aureus remains to be a 
significant problem. Rapid and accurate 
determination of methicillin resistance is important 
for initiation of appropriate antimicrobial therapy. 
Misdiagnosing this resistance leads to treatment 
failures and spread of infections with these resistant 
strains. The increasing reports about vancomycin 
resistance among S.aureus isolates mandate the use 
of glycopeptide antibiotics which yet appear to be 
the only choice, sparingly. Therefore, striving for 
the identification of methicillin resistance as soon as 
bacterial growth is observed is the only way to limit 
the superfluous use of glycopeptide class on 
sensitive isolates.  
 
A major problem in the treatment of S. aureus 
infections is the multidrug resistance pattern of the  
pathogen to a number of antibiotics. In the last few 
years, understanding of the genetic basis for 
methicillin resistance has advanced significantly. 
Multi-resistant MRSA have been reported to be 
relatively high in African countries including 
Morocco, Kenya and Cameroun (22), but their 
antibiotypes were not determined. 
This study has provided baseline information for 
physicians, clinical microbiologists and public 
health officials on critical issues regarding pathogen 
specific therapy. The isolation of MRSA in health 
institution indicates that adequate steps in limiting 
spread are urgently needed. Also, for the first time 
two clones (H and L) according to the PFGE 
classifications have been identified in Nigeria with 
one agr type (1) but no detection of any of the toxin 
genes tested. Continuous surveillance on resistant 
pattern and molecular characterization or 
epidemiological typing in order to generate isolate-
specific genotypic or phenotypic characters that can 
be used to elucidate the source and route of spread 
of MRSA infection in Benin City, Nigeria is relevant 
and of utmost importance. 
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